Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Cost of Revenue (2019 - 2025)

Historic Cost of Revenue for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $438395.7.

  • CureVac's Cost of Revenue fell 9817.98% to $438395.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 9681.12%. This contributed to the annual value of $113.1 million for FY2024, which is 1548.61% down from last year.
  • Latest data reveals that CureVac reported Cost of Revenue of $438395.7 as of Q3 2025, which was down 9817.98% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Cost of Revenue ranged from a high of $135.6 million in Q3 2021 and a low of $438395.7 during Q3 2025
  • Its 5-year average for Cost of Revenue is $38.2 million, with a median of $28.2 million in 2023.
  • Per our database at Business Quant, CureVac's Cost of Revenue soared by 84301.59% in 2021 and then plummeted by 9817.98% in 2025.
  • Quarter analysis of 5 years shows CureVac's Cost of Revenue stood at $80.1 million in 2021, then increased by 1.9% to $81.6 million in 2022, then fell by 29.35% to $57.7 million in 2023, then plummeted by 97.25% to $1.6 million in 2024, then plummeted by 72.37% to $438395.7 in 2025.
  • Its last three reported values are $438395.7 in Q3 2025, $2.5 million for Q2 2025, and $920398.9 during Q1 2025.